Global Biologics Contract Manufacturing Service Market Growth (Status and Outlook) 2022-2028

Global Biologics Contract Manufacturing Service Market Growth (Status and Outlook) 2022-2028

Product Code:446186

Published Date: Dec 19,2022

Pages: 102

Region: Global

Category: Medical Care

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

The global market for Biologics Contract Manufacturing Service is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Biologics Contract Manufacturing Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Biologics Contract Manufacturing Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Biologics Contract Manufacturing Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Biologics Contract Manufacturing Service market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Biologics Contract Manufacturing Service players cover Lonza Group, Samsung Biologics, Thermo Fisher Scientific, Cambrex Corporation and Siegfried Holding AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Biologics Contract Manufacturing Service market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Biologics Contract Manufacturing Service market, with both quantitative and qualitative data, to help readers understand how the Biologics Contract Manufacturing Service market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Biologics Contract Manufacturing Service market and forecasts the market size by Type (Monoclonal Antibodies, Recombinant Proteins and Vaccines), by Application (Large Pharmaceutical Companies and Small And Medium Pharmaceutical Companies.), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
    Monoclonal Antibodies
    Recombinant Proteins
    Vaccines
    Molecular Therapy
    Others

Segmentation by application
    Large Pharmaceutical Companies
    Small And Medium Pharmaceutical Companies

Segmentation by region
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Major companies covered
    Lonza Group
    Samsung Biologics
    Thermo Fisher Scientific
    Cambrex Corporation
    Siegfried Holding AG
    Fujifilm Holding Corporation
    AbbVie, Inc.
    Boehringer Ingelheim
    Recipharm Pharmaceuticals
    WuXi Biologics
    Catalent, Inc.

Chapter Introduction
Chapter 1: Scope of Biologics Contract Manufacturing Service, Research Methodology, etc.
Chapter 2: Executive Summary, global Biologics Contract Manufacturing Service market size and CAGR, Biologics Contract Manufacturing Service market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Biologics Contract Manufacturing Service revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Biologics Contract Manufacturing Service revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Biologics Contract Manufacturing Service market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Lonza Group, Samsung Biologics, Thermo Fisher Scientific, Cambrex Corporation, Siegfried Holding AG, Fujifilm Holding Corporation, AbbVie, Inc., Boehringer Ingelheim and Recipharm Pharmaceuticals, etc.
Chapter 14: Research Findings and Conclusion